CHU de Strasbourg - Nouvel Hôpital Civil

Strasbourg, Bas-Rhin 67091

1 studies enrolling now · 2 studies all time

What they study most

First Line Non-Small Cell Lung Cancer, Immunoglobulin A Nephropathy (IgAN)

Studies at this site

• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed